Guangdong Medi-World Pharmaceutical

Guangdong Medi-World Pharmaceutical, also known as Guangdong Wanle Pharmaceutical, is a leading Chinese pharmaceutical company specializing in the oncology sector. Established in 1990 and headquartered in Shenzhen, the company operates as a key subsidiary of China Resources Pharmaceutical Group. It is recognized as a pioneer in the production of anthracycline antitumor antibiotics in China, maintaining a significant market share for products like epirubicin and daunorubicin. The company's portfolio spans various therapeutic areas, including oncology, cardiovascular health, and anti-infectives, with a strong emphasis on high-quality GMP manufacturing. Medi-World continues to expand its reach through both domestic sales and international exports of its specialized pharmaceutical products.